Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.

Depressive symptoms—serious enough to warrant evaluation by a mental health professional—were experienced by 2.8 percent of ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular ...

In this retrospective cohort study of 3,389 patients with obesity, weight reduction at 1 year was associated with the ...